A phase I clinical study of Rifaximin ER/DER capsulated beads for Sickle Cell Anemia
Latest Information Update: 01 Mar 2022
At a glance
- Drugs Rifaximin (Primary)
- Indications Sickle cell anaemia
- Focus Adverse reactions
- 01 Mar 2022 According to a Bausch Health company pipeline, clinical sites began enrolling into the trial at the end of 2021.
- 01 Mar 2022 New trial record